Quantcast

Latest Brainstem glioma Stories

2014-06-03 13:06:47

Duke University Medical Center A collaborative effort between Duke Medicine researchers and neurosurgeons and scientists in China has produced new genetic insights into a rare and deadly form of childhood and young adult brain cancer called brainstem glioma. The researchers identified a genetic mutation in the tumor cells that plays a role in both the growth and the death of a cell. Additionally, the mutation to the newly identified gene may also contribute to the tumor's resistance to...

2014-05-15 23:13:19

May is brain tumor awareness month. ANS in Morristown discusses Next-Generation Treatments, Community Awareness and their program Partnership of Hope. Morristown, NJ (PRWEB) May 15, 2014 Brain tumors are the second leading cause of cancer related deaths in children and young adults ages 15- 34. For over 50 years, Atlantic NeuroSurgical Specialists (ANS) has maintained their core value that the needs of their patients come first. This means constantly striving toward the application of...

2014-02-04 11:57:02

Largest-ever study of 20-year survival among pediatric low-grade glioma patients highlights radiation's association with higher mortality The first comprehensive, large-scale cohort study of the long-term survival of children treated for low-grade gliomas, the most common pediatric brain tumor, finds that almost 90 percent are alive 20 years later and that few die from the tumor as adults. However, children who received radiation as part of their treatment had significantly lower long-term...

2013-12-16 18:14:37

Rates of programmed cell death higher in mice treated with experimental drug than in untreated animals with same cancer An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology (ASCB) annual meeting in New Orleans. The...

2013-11-25 09:55:06

With standard care, median length of survival is 15 months after diagnosis of glioblastoma multiforme -- and only 10 percent survive more than 5 years Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors – glioblastoma multiforme – survived longer than five years after diagnosis, according to Cedars-Sinai researchers, who presented findings Nov. 23 at the Fourth Quadrennial Meeting of the...

Genetic Pathway Could Be New Target For Pediatric Tumor Treatment
2013-11-07 11:27:12

redOrbit Staff & Wire Reports - Your Universe Online Low-grade gliomas – a type of pediatric brain tumor that is difficult to care for medically – could potentially be treated using a known genetic pathway, according to new research published in Thursday’s edition of the journal Neuro-Oncology. In laboratory studies, Dr. Fausto Rodriguez, assistant professor of pathology and oncology at Johns Hopkins, and colleagues reported that the mammalian target of the rapamycin (mTOR)...

New Laser-based Tool May Improve Accuracy Of Brain Tumor Surgery
2013-09-05 09:00:43

Harvard University In the battle against brain cancer, doctors now have a new weapon -- a new imaging technology that will make brain surgery dramatically more accurate by allowing surgeons to distinguish -- at a microscopic level -- between brain tissue and tumors. Called SRS microscopy -- short for stimulated Raman scattering -- a team of researchers that included Xiaoliang Sunney Xie, the Mallinckrodt Professor of Chemistry and Chemical Biology and Minbiao Ji, a Post-Doctoral Fellow...

2013-08-30 23:28:10

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a new discovery of an immunotherapy target in aggressive brain tumors. New York, NY (PRWEB) August 30, 2013 Voices Against Brain Cancer discusses the discovery of a new immunotherapy target in aggressive brain tumors that could help patients who do not respond to current chemotherapy. According to an August 28, 2013 Med City News article titled “Researchers find new immunotherapy...

2013-05-03 23:02:30

New Jersey neurosurgical practice offers Minimally Invasive Treatments, Community Awareness and a Partnership of Hope Morristown, NJ (PRWEB) May 03, 2013 Brain cancer is the second leading cause of cancer- related deaths in children and young adults. Early detection is extremely important when dealing with cancerous and benign brain tumors. For this reason, Atlantic NeuroSurgical Specialists (ANS) has launched an awareness campaign to educate the community on the importance of choosing a...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related